| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.28 | 5e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |